Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Swallow a thermometer? new study tests pill that takes your temperature from inside

NCT ID NCT04174053

Knowledge-focused Sponsor: Centre Henri Becquerel Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a small, swallowable capsule can accurately measure body temperature in 30 hospitalized patients with blood cancers who have very low immunity (neutropenia). Researchers compared the capsule's temperature readings to standard ear thermometer measurements. The goal was to see if this high-tech method could help doctors detect fevers earlier and start treatments faster.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2019

Finished

Jul 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Major patient admitted to USIH for an aplasia episode of at least 7 days secondary to: * autograft conditioned by melphalan (MLP) or BEAM (BICNU, Etoposide, Aracytine, Melphalan) chemotherapy * Aracytin chemotherapy High dose (HD) or intermediate dose (DI) * Signed informed consent; * Affiliated or beneficiary of a social protection scheme. Exclusion Criteria: * Diarrhea (\> 3 stools /day) at the time of inclusion * Occlusive syndrome at the time of inclusion or patient at risk of developing occlusive syndrome * Persons with or likely to have intestinal disorders that may lead to obstruction of the digestive tract, including diverticulitis * People with digestive tract motility disorders * Persons equipped with a pacemaker or an electro-medical implant * Weight \< 40 kg or BMI \> 30 * Patient for whom an MRI examination may be indicated during the trial period * Patient with proven swallowing disorders * Refusal to participate in the study * Induction of acute leukaemia or allograft * Person under guardianship or curatorship, or deprived of liberty by a judicial or administrative decision * Pregnant, parturient or breastfeeding women; * Patient unable to understand the study for any reason or to comply with the constraints of the trial (language, psychological, geographical problem, etc.) * Patient who has already been included in the TEMPET trial during treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Haematological malignancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Haematological malignancy

Contacts and locations

Locations

  • Centre Henri Becquerel

    Rouen, 76000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.